Literature DB >> 21563750

N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.

Helge Prinz1, Behfar Chamasmani, Kirsten Vogel, Konrad J Böhm, Babette Aicher, Matthias Gerlach, Eckhard G Günther, Peter Amon, Igor Ivanov, Klaus Müller.   

Abstract

A total of 53 N-benzoylated phenoxazines and phenothiazines, including their S-oxidized analogues, were synthesized and evaluated for antiproliferative activity, interaction with tubulin, and cell cycle effects. Potent inhibitors of multiple cancer cell lines emerged with the 10-(4-methoxybenzoyl)-10H-phenoxazine-3-carbonitrile (33b, IC(50) values in the range of 2-15 nM) and the isovanillic analogue 33c. Seventeen compounds strongly inhibited tubulin polymerization with activities higher than or comparable to those of the reference compounds such as colchicine. Concentration-dependent flow cytometric studies revealed that inhibition of K562 cell growth was associated with an arrest in the G2/M phases of the cell cycle, indicative of mitotic blockade. Structure-activity relationship studies showed that best potencies were obtained with agents bearing a methoxy group placed para at the terminal phenyl ring and a 3-cyano group in the phenoxazine. A series of analogues highlight not only the phenoxazine but also the phenothiazine structural scaffold as valuable pharmacophores for potent tubulin polymerization inhibitors, worthy of further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21563750     DOI: 10.1021/jm200436t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective.

Authors:  Jillian S Weissenrieder; Jeffrey D Neighbors; Richard B Mailman; Raymond J Hohl
Journal:  J Pharmacol Exp Ther       Date:  2019-04-18       Impact factor: 4.030

2.  Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061.

Authors:  Gianmatteo Vit; Joana Duro; Girish Rajendraprasad; Emil P T Hertz; Lya Katrine Kauffeldt Holland; Melanie Bianca Weisser; Brennan C McEwan; Blanca Lopez-Mendez; Paula Sotelo-Parrilla; A Arockia Jeyaprakash; Guillermo Montoya; Niels Mailand; Kenji Maeda; Arminja Kettenbach; Marin Barisic; Jakob Nilsson
Journal:  EMBO J       Date:  2022-06-13       Impact factor: 14.012

3.  Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.

Authors:  Ken Morita; Shuning He; Radosław P Nowak; Jinhua Wang; Mark W Zimmerman; Cong Fu; Adam D Durbin; Megan W Martel; Nicole Prutsch; Nathanael S Gray; Eric S Fischer; A Thomas Look
Journal:  Cell       Date:  2020-04-20       Impact factor: 66.850

4.  Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy.

Authors:  Chia-Hsien Wu; Li-Yuan Bai; Ming-Hsui Tsai; Po-Chen Chu; Chang-Fang Chiu; Michael Yuanchien Chen; Shih-Jiuan Chiu; Jo-Hua Chiang; Jing-Ru Weng
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

Review 5.  Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review.

Authors:  Marina C Posso; Fernanda C Domingues; Susana Ferreira; Samuel Silvestre
Journal:  Molecules       Date:  2022-01-03       Impact factor: 4.411

6.  Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors.

Authors:  Riccardo Zanni; Maria Galvez-Llompart; Cecilia Morell; Nieves Rodríguez-Henche; Inés Díaz-Laviada; Maria Carmen Recio-Iglesias; Ramon Garcia-Domenech; Jorge Galvez
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

7.  Metal-free formal synthesis of phenoxazine.

Authors:  Gabriella Kervefors; Antonia Becker; Chandan Dey; Berit Olofsson
Journal:  Beilstein J Org Chem       Date:  2018-06-20       Impact factor: 2.883

8.  O2-Mediated Dehydrogenative Phenoxazination of Phenols.

Authors:  Rajaa Benchouaia; Shiny Nandi; Clemens Maurer; Frederic W Patureau
Journal:  J Org Chem       Date:  2022-03-11       Impact factor: 4.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.